2Festch PA, Abati A. Immunocytochemistry in effusion cytology: a contemponary review[J]. Cancer, 2001, 93(5): 293-308.
3Delahaye M, van der Ham F, van der Kwast TH, et al. Complementary value of five carcinoma markers for the diagnosis of malignant mesothclioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions[J]. Diagn Cytopathol, 1997, 17(2) : 115- 120.
7Lozano MD, Panizo A, Toledo GB, et al. Immunocytochemistry in the diffential diagnosis of serous effusion: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears [ J ]. Cancer, 2001, 93(1):68-72.
8Dejmek A, Hjerpe A. Reactivity of six antibodies in effusions of mesoththelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis[J]. Cytopathology, 2000, 11( 1 ) :8 - 17.
9Haber.MH.Differemtial Diagnosis in Surgical Pathology[M].回允中主译.北京:清华大学出版社,2004.113-114.
二级参考文献12
1Queiroz C, Barral-Netto M, Bacchi CE. Characterizing subpopulations of neoplastic cells in serous effusions. The role of immunocytochemistry. Acta Cytol, 2001, 45:18-22.
2Dejmek A, Hjerpe A. Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis. Cytopathology, 2000, 11:8-17.
3Festch PA, Abati A. Immunocytochemistry in effusion cytology: a contemporary review. Cancer,2001,93:293-308.
4Fetsch PA, Simsir A, Brosky K, et al. Comparison of three commonly used cytologic preparations in effusion immunocytochemistry. Diagn Cytopathol, 2002, 26: 61-66.
5Yun G,Xiaoping S,Claire WM,et al. Immunocytochemistry of serous effusion specimens:a comparison of ThinPrep vs. cell block. Diagn Cytopathol, 2003,28:1-5.
6Maria DL, Angel P, Gemma RT, et al. Immunocytochemistry in the differential diagnosis of serous effusions. A comparative evaluation of eight monoclonal antibodies in Papaniclaou stained smears. Cancer,2001,93: 68-72.
7Grove A, Paulsen SM, Gregersen M. The value of immuno-histochemistry of pleural biopsy specimens in the differential diagnosis between malignant mesothelioma and metastatic carcinoma. Pathol Res Pract, 1990, 190:1044-1055.
8Nagel H, Bernhard H, Ilka R, et al. The value of anti-Calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology. Pathol Res Pract, 1998, 194:759-764.
9Habashi A, Morsi B, Freeman SM, et al. Tumor oncogenic expression in malignant effusions as a possible method to enhance cytologic diagnostic sensitivity. An immunocytochemical study of 87 cases. Am J Clin Pathol, 1995, 103: 206-214.
10Cheepsumon S, Leong AS, Vinyuvat S. Immunostaining of cells preparations: a comparative evaluation of common fixatives and protocols. Diagn Cytopathol, 1996, 15: 167-174.
2Hong E K. The Cytopathology of body cavity fluid [ J ]. Korean J Cytopathol, 2008,19(2) :72 -85.
3Ensani F, Nematizadeh F, Irvanlou G. Accuracy of immunohisto- chemistry in evaluation of malignant pleural and peritoneal effu- sions[ J]. Pol J Pathol, 2011,62(2) :95 - 100.
4Bassarova A V, Nesland J M, Davidson B. D2 -40 is not a spe- cific marker for cells of mesothelial origin in serous effusions [ J ]. Am J Surg Pathol, 2006,30(7) :878 -82.
5Sayed D M, el-Attar M M, Hussein A A. Evaluation of flow cyto- metric immunophenotyping and DNA analysis for detection of ma- lignant cells in serosal cavity fluids[J]. Diagn Cytopathol, 2009, 37(7) :498 -504.
6Davidson B. Malignant effusions: from diagnosis to biology [ J ]. Diagn Cytopathol, 2004,31 (4) :246 - 54.
7Thapar M, Mishra R K, Sharma A, Critical analysis of cell block versus smear examination in effusions[ J]. J Cytol, 2009,26 ( 2 ) : 60 - 4.
8Bigras G, Rieder M A, Lambercy J M, et al. Keeping Collecting device in liquid mediem is mandatory to ensure optimized liquid- based cervical cytologic sampling [ J ]. J Low Genit Tract Dis, 2003,7(3) :168 -74.
9Biship J W. Comparision of the eytoRich system with conventional cervical cytology: Preliminary data on 2 032 eases from a clinicaltrial site[ J]. Acta Cytol, 1997,41 ( 1 ) : 15 - 23.
10Nanee K V. Evolution of pap test at a community hospital: a ten year experence [ J ]. Diagn Cytopathol, 2007,35 (3) : 148 - 53.
